Evidence map›Paper›PMID 36287917›Full record

ReviewToxins2022

Homeostasis in the Gut Microbiota in Chronic Kidney Disease.

Shruti Bhargava, Erik Merckelbach, Heidi Noels, Ashima Vohra, Joachim Jankowski

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. International journal of molecular sciences · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Shruti BhargavaInstitute of Molecular Cardiovascular Research, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.
Erik MerckelbachInstitute of Molecular Cardiovascular Research, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.
Heidi NoelsInstitute of Molecular Cardiovascular Research, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.ORCID 0000-0003-3053-6984
Ashima VohraInstitute of Home Economics, Delhi University, Delhi 110021, India.ORCID 0000-0003-4368-3473
Joachim JankowskiInstitute of Molecular Cardiovascular Research, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.
RWTH Aachen University · DEMaastricht University · NLUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota consists of trillions of microorganisms, fulfilling important roles in metabolism, nutritional intake, physiology and maturation of the immune system, but also aiding and abetting the progression of chronic kidney disease (CKD). The human gut microbiome consists of bacterial species from five major bacterial phyla, namely

Indexed as

Gastrointestinal MicrobiomeRenal Insufficiency, ChronicAminesBacteriaEndotoxinsHomeostasisHumansIndolesPhenolsUremic ToxinsWaterAminesEndotoxinsIndolesPhenolsUremic ToxinsWateralterations of the gut microbiomegut-derived uremic metabolitesgut permeabilitypathogenic bacteria in CKD

Identifiers

PMID36287917
PMCPMC9610479
OpenAlexW4296745816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.